COH General Information
| Cochlear Limited | |
| COH | |
| http://www.cochlear.com | |
| Health Care Equipment | |
| 9,840 | |
| 58 |
COH Current Share Price+
| Current Price | $170.500 |
| Open | $169.510 |
| High | $171.850 |
| Low | $168.230 |
| Last Close | $169.680 |
| Volume | 619337 |
| Price Movement | $0.82 ( 0.48% ) |
- +Security prices are delayed by at least 20 minutes and are indicative only.
COH Research
COH Company Overview
Business Description
COH Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2020 F | 295.86 | 515.20 | 9.20% | 32.93 | 360.64 | 2.13% | 100.0% |
| 2019 F | 270.89 | 471.71 | 10.50% | 35.97 | 330.20 | 1.95% | 100.0% |
| 2018 A | 245.85 | 426.80 | 9.70% | 40.79 | 300.00 | 1.72% | 100.0% |
COH Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2018 A | 2019 F | 2020 F | 2018 A | 2019 F | 2020 F | 2018 A | 2019 F | 2020 F | ||
| Cochlear (COH) | $9,849M | 0.0828 | 0.1314 | 0.1144 | 40.5037 | 35.7997 | 32.1242 | 1.76% | 1.92% | 2.12% |
| Fisher & Paykel Hlth (FPH) | $8,002M | 0.1095 | 0.0438 | 0.1405 | 41.5921 | 39.8458 | 34.9361 | 1.43% | 1.69% | 1.98% |
| ResMed (RMD) | $5,598M | 0.2815 | 0.0556 | 0.1410 | 32.3382 | 30.6347 | 26.8496 | 1.35% | 1.73% | 1.98% |
COH Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 1.04 | 37.10 | 16.00 | 3.26 |
| Market | 0.92 | 16.70 | 1.52 | 1.73 |
| Sector | 0.82 | 17.50 | 1.68 | 2.76 |
COH Directors
| Name | Position | Start Date |
|---|---|---|
| Ms Catriona Alison Deans | Non-Executive Director | 1 Jan 2015 |
| Mr Andrew Leslie Denver | Non-Executive Director | 1 Feb 2007 |
| Ms Yasmin Anita Allen | Non-Executive Director | 2 Aug 2010 |
| Mr Donal Paul O'Dwyer | Non-Executive Director | 1 Aug 2005 |
| Mr Glen Francis Boreham | Non-Executive Director | 1 Jan 2015 |
| Professor Bruce Gregory Robinson | Non-Executive Director | 13 Dec 2016 |
| Mr Shah Abbas Hussain | Non-Executive Director | 20 Nov 2018 |
| Mr Roderic (Rick) Holliday-Smith | Non-Executive Director, Non-Executive Chairman | 1 Mar 2005 |
| Mr Dig Howitt | President, Chief Executive Officer, Managing Director | 14 Nov 2017 |
COH Management
| Name | Position |
|---|---|
| Brent Cubis | Chief Financial Officer |
| David Hackshall | Chief Information Officer |
| David Cade | Chief Medical Officer |
| Jan Janssen | Chief Technology Officer |
| Ray Jarman | Company Secretary |
| Rom Mendel | President, Acoustics |
| Tony Manna | President, Americas Region |
| Anthony Bishop | President, Asia Pacific Region |
| Richard Brook | President, EMEA & Latin American Region |
| Stu Sayers | President, Services |
| Dean Phizacklea | Senior Vice President, Global Marketing |
| Jennifer Hornery | Senior Vice President, People & Culture |
| Greg Bodkin | Senior Vice President, Supply Chain & Operational Excellence |
COH Substantial Shareholders
| Holding | Name |
|---|---|
| 4,532,973 (7.90%) | Baillie Gifford & Co |
| 3,457,684 (6%) | BlackRock Group |
COH Calendar of Events
| Date | Event |
|---|---|
| 18 February 2020 | Report (Interim) |
| 13 August 2019 | Report (Annual) |
| 13 August 2019 | Report (Prelim) |
| 16 April 2019 | Div Pay Date |
| 26 March 2019 | Books Close |
| 25 March 2019 | Div Ex Date |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.